Target intelligence / Profile preview

Novel transcript, antisense to LPP

Molecular classification
Long non-coding RNA (lncRNA), Antisense transcript
01

Overview

"Novel transcript, antisense to LPP" (ENSG00000308437) is a long non-coding RNA gene annotation, representing an RNA molecule transcribed from the DNA strand opposite to the LPP gene locus. Antisense transcripts commonly participate in regulating gene expression by various mechanisms such as modulation of chromatin state, interference with sense transcript processing, and contributing to transcriptional dynamics[1][4]. However, for this specific transcript, no protein product, biological function, or disease association has been established, and it is not considered a validated therapeutic target. Notes: - This entry is not a receptor or a protein and should not be considered a therapeutic target according to established biomedical criteria. - The presence of "novel" in the canonical name reflects its annotation status, not validated functional characterization. - The Ensembl ID "ENSG00000308437" does not match standard Ensembl gene ID patterns (typical pattern: ENSG00000000001–ENSG00000299999) and may be erroneously referenced. This increases the likelihood of this being a non-standard or placeholder entry, further supporting the "is_incorrect: true" assessment.

02

Biological functions

Gene expression regulation (inferred from general literature on antisense transcripts)Chromatin modification (supported by antisense RNA regulation studies)Other (generic, due to lack of specific evidence for this transcript)
03

Disease associations

Unknown/Other

Beyond the preview

Go deeper on Novel transcript, antisense to LPP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to LPP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call